Proshares Ultra Health Etf Performance

RXL Etf  USD 50.99  1.12  2.15%   
The etf holds a Beta of 1.29, which implies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, ProShares Ultra will likely underperform.

Risk-Adjusted Performance

Fair

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in ProShares Ultra Health are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. Despite quite unsteady basic indicators, ProShares Ultra may actually be approaching a critical reversion point that can send shares even higher in March 2026. ...more
1
Hot Stocks ActivePort Group, Rox Resources, Battery Age Minerals
11/10/2025
2
Individual investors in Rox Resources Limited are its biggest bettors, and their bets paid off as stock gained 10 percent last week
12/03/2025
3
Up 130 percent in a year, ASX All Ords gold stock lifts off on valuable gold price protection news
12/22/2025
4
Venus Metals to launch PFS over WA Sandstone gold project
12/29/2025
5
Roxs Pathway to Production
01/14/2026
6
Rox Resources Insider Stock Sales Prove Timely As Market Valuation Descends To AU750m
02/02/2026

ProShares Ultra Relative Risk vs. Return Landscape

If you would invest  4,627  in ProShares Ultra Health on November 6, 2025 and sell it today you would earn a total of  472.00  from holding ProShares Ultra Health or generate 10.2% return on investment over 90 days. ProShares Ultra Health is generating 0.1789% of daily returns assuming volatility of 1.8603% on return distribution over 90 days investment horizon. In other words, 16% of etfs are less volatile than ProShares, and above 97% of all equities are expected to generate higher returns over the next 90 days.
  Expected Return   
       Risk  
Considering the 90-day investment horizon ProShares Ultra is expected to generate 2.48 times more return on investment than the market. However, the company is 2.48 times more volatile than its market benchmark. It trades about 0.1 of its potential returns per unit of risk. The Dow Jones Industrial is currently generating roughly 0.11 per unit of risk.
Below is the normalized historical share price chart for ProShares Ultra Health extending back to February 01, 2007. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of ProShares Ultra stands at 50.99, as last reported on the 4th of February, with the highest price reaching 52.57 and the lowest price hitting 50.98 during the day.
3 y Volatility
27.03
200 Day MA
44.4407
1 y Volatility
32.17
50 Day MA
52.1806
Inception Date
2007-01-30
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
 
Interest Hikes

ProShares Ultra Target Price Odds to finish over Current Price

The tendency of ProShares Etf price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to move above the current price in 90 days
 50.99 90 days 50.99 
about 51.1
Based on a normal probability distribution, the odds of ProShares Ultra to move above the current price in 90 days from now is about 51.1 (This ProShares Ultra Health probability density function shows the probability of ProShares Etf to fall within a particular range of prices over 90 days) .
Considering the 90-day investment horizon the etf has the beta coefficient of 1.29 indicating as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, ProShares Ultra will likely underperform. Additionally ProShares Ultra Health has an alpha of 0.1386, implying that it can generate a 0.14 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta).
   ProShares Ultra Price Density   
       Price  

Predictive Modules for ProShares Ultra

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as ProShares Ultra Health. Regardless of method or technology, however, to accurately forecast the etf market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the etf market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of ProShares Ultra's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
49.1550.9952.83
Details
Intrinsic
Valuation
LowRealHigh
50.3252.1654.00
Details
Naive
Forecast
LowNextHigh
48.5250.3752.21
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
50.5552.7654.96
Details

ProShares Ultra Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. ProShares Ultra is not an exception. The market had few large corrections towards the ProShares Ultra's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold ProShares Ultra Health, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of ProShares Ultra within the framework of very fundamental risk indicators.
α
Alpha over Dow Jones
0.14
β
Beta against Dow Jones1.29
σ
Overall volatility
2.53
Ir
Information ratio 0.08

ProShares Ultra Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of ProShares Ultra for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for ProShares Ultra Health can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
Latest headline from simplywall.st: Rox Resources Insider Stock Sales Prove Timely As Market Valuation Descends To AU750m
The fund maintains 200.06% of its assets in stocks

ProShares Ultra Fundamentals Growth

ProShares Etf prices reflect investors' perceptions of the future prospects and financial health of ProShares Ultra, and ProShares Ultra fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on ProShares Etf performance.

About ProShares Ultra Performance

By examining ProShares Ultra's fundamental ratios, stakeholders can obtain critical insights into ProShares Ultra's financial health, operational efficiency, and overall profitability. These insights assist in making well-informed investment and management decisions. For example, a high Return on Assets and Return on Equity would indicate that ProShares Ultra is effectively utilizing its assets and equity to generate significant profits, enhancing its appeal to investors. On the other hand, low ROA and ROE values could reveal issues in asset and equity management, highlighting the need for operational improvements.
The fund invests in financial instruments that ProShare Advisors believes, in combination, should produce daily returns consistent with the funds investment objective. Ultra Health is traded on NYSEARCA Exchange in the United States.
Latest headline from simplywall.st: Rox Resources Insider Stock Sales Prove Timely As Market Valuation Descends To AU750m
The fund maintains 200.06% of its assets in stocks
When determining whether ProShares Ultra Health is a strong investment it is important to analyze ProShares Ultra's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact ProShares Ultra's future performance. For an informed investment choice regarding ProShares Etf, refer to the following important reports:
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in ProShares Ultra Health. Also, note that the market value of any etf could be closely tied with the direction of predictive economic indicators such as signals in median.
You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.
The market value of ProShares Ultra Health is measured differently than its book value, which is the value of ProShares that is recorded on the company's balance sheet. Investors also form their own opinion of ProShares Ultra's value that differs from its market value or its book value, called intrinsic value, which is ProShares Ultra's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ProShares Ultra's market value can be influenced by many factors that don't directly affect ProShares Ultra's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
It's important to distinguish between ProShares Ultra's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding ProShares Ultra should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Meanwhile, ProShares Ultra's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.